Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Satoshi Miyake

Showing results (51-60 of 55) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 55 results.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|November 22, 2019
[Clinical Utility of Comprehensive Genome Profiling Using FoundationOne CDx in Japanese Population(PROFILE-F Study)]Yuichi Kumaki, Kenta Takahashi, Takahiro Mitsumura, et al.
Medicine|August 10, 2020
A phase 2 basket trial of combination therapy with trastuzumab and pertuzumab in patients with solid cancers harboring human epidermal growth factor receptor 2 amplification (JUPITER trial)Kenta Takahashi, Eri Ishibashi, Toshio Kubo, et al.
Cancers|July 27, 2022
Comprehensive Genomic Profiling Reveals Clinical Associations in Response to Immune Therapy in Head and Neck CancerRika Noji, Kohki Tohyama, Takuma Kugimoto, et al.
Plos One|March 31, 2022
Clinical utility of comprehensive genomic profiling in Japan: Result of PROFILE-F studyYasuko Aoyagi, Yoshihito Kano, Kohki Tohyama, et al.
Annals of Surgical Oncology|March 29, 2021
A Pilot Study Analyzing the Clinical Utility of Comprehensive Genomic Profiling Using Plasma Cell-Free DNA for Solid Tumor Patients in Japan (PROFILE Study)Shotaro Matsudera, Yoshihito Kano, Yasuko Aoyagi, et al.
Pageof 6

Showing results (51-60 of 55) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 55 results.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|November 22, 2019
[Clinical Utility of Comprehensive Genome Profiling Using FoundationOne CDx in Japanese Population(PROFILE-F Study)]Yuichi Kumaki, Kenta Takahashi, Takahiro Mitsumura, et al.
Medicine|August 10, 2020
A phase 2 basket trial of combination therapy with trastuzumab and pertuzumab in patients with solid cancers harboring human epidermal growth factor receptor 2 amplification (JUPITER trial)Kenta Takahashi, Eri Ishibashi, Toshio Kubo, et al.
Cancers|July 27, 2022
Comprehensive Genomic Profiling Reveals Clinical Associations in Response to Immune Therapy in Head and Neck CancerRika Noji, Kohki Tohyama, Takuma Kugimoto, et al.
Plos One|March 31, 2022
Clinical utility of comprehensive genomic profiling in Japan: Result of PROFILE-F studyYasuko Aoyagi, Yoshihito Kano, Kohki Tohyama, et al.
Annals of Surgical Oncology|March 29, 2021
A Pilot Study Analyzing the Clinical Utility of Comprehensive Genomic Profiling Using Plasma Cell-Free DNA for Solid Tumor Patients in Japan (PROFILE Study)Shotaro Matsudera, Yoshihito Kano, Yasuko Aoyagi, et al.
Pageof 6